Functional dissection of the human spumaretrovirus transactivator identifies distinct classes of dominant-negative mutants
- PMID: 8380068
- PMCID: PMC237348
- DOI: 10.1128/JVI.67.1.161-169.1993
Functional dissection of the human spumaretrovirus transactivator identifies distinct classes of dominant-negative mutants
Abstract
The bel1 gene of human spumaretrovirus (HSRV) codes for a 300-amino-acid nuclear protein, termed Bel1, that can strongly activate transcription from the cognate long terminal repeat (LTR) by at least 200-fold. Bel1 can also activate human immunodeficiency virus type 1 (HIV-1) LTR expression. By using site-directed mutagenesis, we have identified distinct regions of Bel1 essential for HSRV LTR activation. The amino-terminal 55 residues, which comprise a highly acidic region followed by a short basic stretch, were dispensable for activation. The distribution of functionally defective mutants indicates that two distinct regions between residues 56 and 300 cooperate to confer full activator function. The larger, more amino-terminal region between residues 56 and 227 is sufficient to minimally activate the HSRV LTR. It contains a region between residues 88 and 110 that is strongly conserved between the simian and human spumavirus transactivators but otherwise lacks obvious homology to known transcriptional activators except for an Arg-rich nuclear localization sequence (NLS) between residues 211 and 225 that can be functionally substituted for by the NLS of the simian virus 40 large T antigen. The carboxy-terminal 73 residues contain two functionally redundant regions that can independently augment the activity of the more N-terminal minimal activator domain by 30- to 90-fold. Comparative analysis of the effect of Bel1 mutations on HSRV and HIV-1 LTR expression revealed a similar requirement of Bel1 domains for activation of the two LTRs. Bel1 is phosphorylated in vivo, and a nuclear localization-defective mutant lacking residues 211 to 222 was severely defective for phosphorylation, whereas various deletion mutations in residues 228 to 300 resulted in a four- to eightfold reduction in phosphate incorporation. When functionally defective bel1 mutants were examined for a dominant-negative phenotype, only mutants lacking a proline-rich basic region between residues 194 and 200 or the NLS between residues 211 and 222 that were found to occupy predominantly nuclear and cytoplasmic locations, respectively, could suppress wild-type Bel1 function efficiently. In identifying two classes of dominant-negative mutants with distinct subcellular localization phenotypes, the mutational analysis of Bel1 has revealed a feature unusual for known transcriptional activators.
Similar articles
-
The carboxy-terminal transcription enhancement region of the human spumaretrovirus transactivator contains discrete determinants of the activator function.J Virol. 1993 Jul;67(7):3868-76. doi: 10.1128/JVI.67.7.3868-3876.1993. J Virol. 1993. PMID: 8389909 Free PMC article.
-
The Bel1 protein of human foamy virus contains one positive and two negative control regions which regulate a distinct activation domain of 30 amino acids.J Virol. 1994 Apr;68(4):2708-19. doi: 10.1128/JVI.68.4.2708-2719.1994. J Virol. 1994. PMID: 8139046 Free PMC article.
-
Distinct cis-acting regions in U3 regulate trans-activation of the human spumaretrovirus long terminal repeat by the viral bel1 gene product.Nucleic Acids Res. 1991 Jul 11;19(13):3661-6. doi: 10.1093/nar/19.13.3661. Nucleic Acids Res. 1991. PMID: 1649456 Free PMC article.
-
Transactivation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by the human foamy virus bel1 protein requires a specific DNA sequence.J Virol. 1992 May;66(5):3236-40. doi: 10.1128/JVI.66.5.3236-3240.1992. J Virol. 1992. PMID: 1313928 Free PMC article.
-
Multiple positive and negative cis-acting elements that mediate transactivation by bel1 in the long terminal repeat of human foamy virus.J Virol. 1993 Apr;67(4):2317-26. doi: 10.1128/JVI.67.4.2317-2326.1993. J Virol. 1993. PMID: 8383244 Free PMC article.
Cited by
-
Expression and maturation of human foamy virus Gag precursor polypeptides.J Virol. 1997 Feb;71(2):1635-9. doi: 10.1128/JVI.71.2.1635-1639.1997. J Virol. 1997. PMID: 8995691 Free PMC article.
-
Transcriptional mapping of the 3' end of the bovine syncytial virus genome.J Virol. 1994 Feb;68(2):1021-8. doi: 10.1128/JVI.68.2.1021-1028.1994. J Virol. 1994. PMID: 8289332 Free PMC article.
-
The transcriptional transactivator of simian foamy virus 1 binds to a DNA target element in the viral internal promoter.Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):326-30. doi: 10.1073/pnas.93.1.326. Proc Natl Acad Sci U S A. 1996. PMID: 8552631 Free PMC article.
-
The human foamy virus internal promoter directs the expression of the functional Bel 1 transactivator and Bet protein early after infection.J Virol. 1994 Feb;68(2):638-45. doi: 10.1128/JVI.68.2.638-645.1994. J Virol. 1994. PMID: 8289367 Free PMC article.
-
Human foamy virus Bel 1 transactivator/estrogen receptor fusion proteins allow inducible transactivation of both human foamy virus promoters.Virus Genes. 2000 Oct;21(3):209-13. doi: 10.1023/a:1008143615032. Virus Genes. 2000. PMID: 11129637
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources